Mapping Your China Exposure: A Strategic Guide for Boards
In today's volatile geopolitical climate, a static risk briefing is no longer sufficient for board oversight. I recommend building a dynamic U.S.-China exposure map that integrates regulatory, commercial, financial, and operational data to drive decisive action on supply-chain resilience and compliance.
Why Boards Need an Exposure Map, Not a Briefing
In my experience, most boards receive risk briefings that are snapshots in time, often outdated by the time they are presented. A risk briefing tells you what happened, but an exposure map tells you where you are vulnerable. As founder of Artisan Business Group, I tell clients that you cannot manage what you have not mapped. An exposure map is a living document that visualizes your firm's interconnectedness with the Chinese market. It moves beyond high-level sentiment to identify specific nodes of dependency. Whether it is reliance on a single-source supplier in a high-risk region or a joint venture that could trigger a CFIUS review, the map forces the board to confront the reality of their footprint. It transforms abstract geopolitical anxiety into a structured dashboard that tracks regulatory shifts, such as the evolving UFLPA Entity List or outbound investment restrictions, against your actual business activities. This is not just about compliance, it is about strategic agility.
The Four Dimensions of Exposure
To build a robust map, I categorize exposure into four distinct dimensions. First, the regulatory dimension covers your compliance with U.S. export controls, the UFLPA, and potential outbound investment screening. You must track if your partners or suppliers appear on the UFLPA Entity List or if your technology transfers fall under new restricted categories. Second, the commercial dimension assesses your revenue concentration and market access. Are you overly dependent on Chinese end-users who might be subject to future sanctions? Third, the financial dimension looks at capital flow, including the risk of asset freezes or the inability to repatriate profits. Finally, the operational dimension is where the rubber meets the road. This includes your physical supply chain, logistics, and data governance. I recommend that boards demand a quarterly update on these four pillars. By quantifying these areas, you can identify which business units are 'high-exposure' and require immediate mitigation, versus those that are manageable under current conditions.
Quantifying the Taiwan Contingency
The Taiwan contingency is the most complex variable in any U.S.-China exposure map. I advise clients to treat this not as a binary 'yes or no' event, but as a spectrum of disruption. To quantify this, we look at three specific indicators. First, we map the 'chokepoint dependency' of your critical components. If your production relies on semiconductors or specialized materials sourced through or manufactured in the Taiwan Strait, your exposure is critical. Second, we assess the 'logistical velocity' of your supply chain. How many days of inventory do you hold, and how quickly can you pivot to alternative manufacturing hubs in Southeast Asia or Mexico? Third, we evaluate the 'financial contagion' risk. This involves stress-testing your balance sheet against a scenario where trade routes are restricted or insurance premiums spike. By assigning a probability-weighted impact score to these indicators, the board can move from vague concern to a concrete understanding of the capital required to hedge against a potential crisis.
Driving Board-Level Decisions
Once the map is built, it must drive action. I use the exposure map to help boards prioritize three specific areas. First, hedging. If the map shows high financial exposure, we look at currency hedging or diversifying banking relationships to mitigate the risk of capital controls. Second, supply-chain transitions. The map will highlight which suppliers are the weakest links. I recommend using this data to justify the cost of 'China plus one' strategies, moving from a reactive posture to a proactive, phased transition. Third, compliance investments. If your map reveals gaps in your UFLPA or export control protocols, you have the data to authorize immediate budget for independent third-party audits and supply-chain transparency tools. When you present this to the board, you are not asking for money to 'fix risk' in the abstract. You are presenting a clear, data-backed case for protecting the firm's long-term viability. This is how you turn geopolitical risk from a liability into a competitive advantage.
Frequently Asked Questions
How often should the board review the exposure map?
I recommend a formal review on a quarterly cadence. However, the map should be updated in real-time by your internal risk team whenever there is a significant regulatory change, such as a new UFLPA enforcement action or a major CFIUS policy update.
What is the first step if our map reveals high exposure to a sanctioned entity?
First, pause all transactions with that entity to prevent further compliance breaches. Second, conduct an immediate internal audit to determine the extent of your historical exposure. Third, consult with legal counsel to prepare a voluntary disclosure if necessary, and begin identifying alternative suppliers to ensure business continuity.
Need advisory on Geopolitical Risk Advisory?
Brian B. Su works directly with decision-makers.
